1. Home
  2. MBRX vs LRE Comparison

MBRX vs LRE Comparison

Compare MBRX & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$2.12

Market Cap

16.1M

Sector

Health Care

ML Signal

HOLD

Logo Lead Real Estate Co. Ltd

LRE

Lead Real Estate Co. Ltd

HOLD

Current Price

$1.43

Market Cap

16.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBRX
LRE
Founded
2015
2001
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.1M
16.8M
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
MBRX
LRE
Price
$2.12
$1.43
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$61.00
N/A
AVG Volume (30 Days)
516.1K
9.6K
Earning Date
05-12-2026
07-30-2015
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.16
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$1.00
52 Week High
$7.98
$2.86

Technical Indicators

Market Signals
Indicator
MBRX
LRE
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
MBRX
LRE

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: